Upvote Story 11

Pilot Feasibility Study of Therapeutic Hypothermia for Moderate to Severe ARDS

Pilot Feasibility Study of Therapeutic Hypothermia for Moderate to Severe ARDS

Neuromuscular blockade alone does not cause hypothermia but allowed acute respiratory distress syndrome patients to be effectively cooled. Results support conducting a randomized clinical trial of hypothermia in acute respiratory distress syndrome and the feasibility of studying acute respiratory distress syndrome patients receiving neuromuscular blockade.

CriticalCare.news
December 27, 2017

Leave Your Comment